Clinical Trial Update: Treatment of Uncomplicated Childhood Malaria in Tanzania by Artemether+Lumefantrine - Efficacy and Genotyping [Phase 4]

View source ↗

Summary

Phase 4 trial evaluated the efficacy of artemether–lumefantrine for uncomplicated childhood malaria in Tanzania, with genotyping to assess resistance markers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• artemether (artemether)
• lumefantrine (lumefantrine)

Snippet

Sponsor: Karolinska University Hospital | Conditions: Malaria | Phase 4 | Status: COMPLETED